• Linda A Jacobs and Lawrence N Shulman.
• Director for Survivorship Clinical Programs, Research and Educational Initiatives, Abramson Cancer Center, Perelman Center for Advanced Medicine, Philadelphia, PA, USA. Electronic address: linda.jacobs@uphs.upenn.edu.
• Lancet Oncol. 2017 Jan 1; 18 (1): e19-e29.

AbstractAttention to survivors of adult cancers formally began more than 30 years ago with the founding of the National Coalition for Cancer Survivorship by representatives from 20 organisations who envisioned an organisation that would address survivorship issues and include friends, family, and caregivers. Since then, progress has been made in cancer care delivery, which has created challenges for and barriers to provision of optimal follow-up care to patients and survivors living with cancer as a chronic illness. Focus on post-treatment cancer care, including monitoring for long-term and late effects, and concerns regarding the effect of a cancer diagnosis and treatment on quality of life have gained momentum in the past 10 years. This impetus is largely a result of the 2005 Institute of Medicine Report From Cancer Patient to Cancer Survivor: Lost in Transition. Although the issues raised in the report were hardly novel, they gave a new and powerful voice to the cancer survivorship movement that demanded a call to action. In this Series paper, we provide an overview of the issues surrounding provision of cancer survivorship and follow-up care in the USA and discuss potential solutions to these challenges.Copyright © 2017 Elsevier Ltd. All rights reserved.

14 keywords...

hide…